Received Mar 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 3 | Unknown | — |
The patient missed the fourth dose of Vivotif; Case reference number US-BN-2024-002311 is a spontaneous case initially received from nurse via agency (reference number: USBAV24-1882) on 05-Aug-2024 and concerns patient of unspecified age or gender. The patient's medical history and concomitant medication details were not provided. On unspecified dates, the patient took three doses of Vivotif (batch number: unknown), at an unknown dose, route or site of administration, for unknown indication. As reported, only a day or longer than a week since (to be confirmed) the patient missed the fourth dose of Vivotif (explicitly coded as 'missed dose'). At the time of the initial report, it was unknown if the patient experienced any adverse event due to Vivotif. Non-significant follow-up was downloaded from VAERS on 09-May-2025 included new reference number. Administrative update performed within the case: Worldwide Unique Case Identification Number (WWID) updated from US-20240805-7b894d to US-BAVARIAN NORDIC A/S-US-BN-2024-002311, in accordance with ICH guidance on WWID formatting.; Reporter's Comments: A patient of unspecified age or gender missed the fourth dose of Vivotif which is considered as missed dose. Product dose omission issue is considered listed per company convention. At this point, it was unknown if the patient experienced any adverse event due to Vivotif. The patient's medical history and concomitant medication details were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.; Sender's Comments: A patient of unspecified age or gender missed the fourth dose of Vivotif which is considered as missed dose. Product dose omission issue is considered listed per company convention. At this point, it was unknown if the patient experienced any adverse event due to Vivotif. The patient's medical history and concomitant medication details were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.
Comments: None